This Special call will seek innovative proposals to develop therapeutics for severe unmet needs that can be brought rapidly to EB patients: as such, there will be a strong focus on repurposing well-evidenced therapeutics towards clinical testing, to deliver:
Increased resolution of non-healing wounds
Prevention and/or reduction of chronic inflammation
Inhibition and/or reduction of fibrosis
Decreased risk of squamous cell carcinoma (SCC) initiation in EB
The funding round will be organised in a two-stage application process, with an EOI submission in the summer.
Main deadlines
Application Step | Date |
Call for EOI opens | 10 July 2023 |
Deadline for EOI submission | 10 September 2023 |
Shortlisted EOI applicants invited to submit full applications; Call for full applications opens | 04 October 2023 |
Deadline for full application submission | 04 December 2023 |
Funding decision, and sucessful applicants notified of outcome | By 01 April 2024 |
Project start | By 01 July 2024 |
All details, EOI application template & guidance document for submission are provided on LifeArc's joint call website.
Related news articles: Joint funding call & Prioritization workshop on EB unmet medical needs